KORU Medical Systems Management
Management criteria checks 4/4
KORU Medical Systems' CEO is Linda Tharby, appointed in Apr 2021, has a tenure of 3.75 years. total yearly compensation is $713.37K, comprised of 78.9% salary and 21.1% bonuses, including company stock and options. directly owns 3.97% of the company’s shares, worth $7.28M. The average tenure of the management team and the board of directors is 3 years and 3.7 years respectively.
Key information
Linda Tharby
Chief executive officer
US$713.4k
Total compensation
| CEO salary percentage | 78.9% |
| CEO tenure | 3.8yrs |
| CEO ownership | 4.0% |
| Management average tenure | 3yrs |
| Board average tenure | 3.7yrs |
Recent management updates
Recent updates
KORU Medical Systems, Inc. (NASDAQ:KRMD) Released Earnings Last Week And Analysts Lifted Their Price Target To US$4.10
Nov 16
Impressive Turnaround At KORU Medical
Nov 06We're Interested To See How KORU Medical Systems (NASDAQ:KRMD) Uses Its Cash Hoard To Grow
Aug 29KORU Medical Systems, Inc. (NASDAQ:KRMD) Doing What It Can To Lift Shares
Jul 30Market Cool On KORU Medical Systems, Inc.'s (NASDAQ:KRMD) Revenues
Feb 15We're Hopeful That KORU Medical Systems (NASDAQ:KRMD) Will Use Its Cash Wisely
Sep 21Market Cool On KORU Medical Systems, Inc.'s (NASDAQ:KRMD) Earnings Pushing Shares 28% Lower
Jul 14We're Not Very Worried About KORU Medical Systems' (NASDAQ:KRMD) Cash Burn Rate
Sep 27Repro Med Systems (NASDAQ:KRMD) Is In A Good Position To Deliver On Growth Plans
Oct 27Analysts Have Been Trimming Their Repro Med Systems, Inc. (NASDAQ:KRMD) Price Target After Its Latest Report
Aug 14Is Repro Med Systems, Inc.'s (NASDAQ:KRMD) Shareholder Ownership Skewed Towards Insiders?
Feb 22Returns On Capital At Repro Med Systems (NASDAQ:KRMD) Paint An Interesting Picture
Jan 27CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$12m |
| Jun 30 2024 | n/a | n/a | -US$12m |
| Mar 31 2024 | n/a | n/a | -US$13m |
| Dec 31 2023 | US$713k | US$563k | -US$14m |
| Sep 30 2023 | n/a | n/a | -US$8m |
| Jun 30 2023 | n/a | n/a | -US$8m |
| Mar 31 2023 | n/a | n/a | -US$9m |
| Dec 31 2022 | US$1m | US$550k | -US$9m |
| Sep 30 2022 | n/a | n/a | -US$8m |
| Jun 30 2022 | n/a | n/a | -US$8m |
| Mar 31 2022 | n/a | n/a | -US$6m |
| Dec 31 2021 | US$7m | US$398k | -US$5m |
Compensation vs Market: Linda's total compensation ($USD713.37K) is below average for companies of similar size in the US market ($USD1.40M).
Compensation vs Earnings: Linda's compensation has been consistent with company performance over the past year.
CEO
Linda Tharby (56 yo)
3.8yrs
Tenure
US$713,369
Compensation
Ms. Linda M. Tharby serves as President and Chief Executive Officer at KORU Medical Systems, Inc. (formerly known as Repro Med Systems, Inc.) since April 12, 2021 and serves as its Director since May 06, 2...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.8yrs | US$713.37k | 3.97% $ 7.3m | |
| CFO, Secretary & Treasurer | 1.4yrs | US$555.40k | 0.22% $ 400.0k | |
| Chief Commercial Officer | 1.2yrs | US$717.22k | no data | |
| Chief Operating Officer | 3yrs | no data | 0.050% $ 92.3k | |
| Vice President of Sales | 4yrs | no data | no data |
3.0yrs
Average Tenure
55yo
Average Age
Experienced Management: KRMD's management team is considered experienced (3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2.7yrs | US$713.37k | 3.97% $ 7.3m | |
| Director | 1.3yrs | US$28.10k | 0.060% $ 110.9k | |
| Independent Chairman of the Board | 5.7yrs | US$140.00k | 0.43% $ 787.0k | |
| Independent Director | 2.7yrs | US$125.00k | 0.16% $ 298.2k | |
| Lead Independent Director | 8.9yrs | US$121.50k | 0.36% $ 661.0k | |
| Independent Director | 3.7yrs | US$110.00k | 0.17% $ 310.2k | |
| Independent Director | 3.7yrs | US$110.00k | 0.16% $ 299.7k |
3.7yrs
Average Tenure
59yo
Average Age
Experienced Board: KRMD's board of directors are considered experienced (3.7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 01:28 |
| End of Day Share Price | 2025/01/08 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
KORU Medical Systems, Inc. is covered by 11 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Neil Chatterji | B. Riley Securities, Inc. |
| Kyle Bauser | B. Riley Securities, Inc. |
| Kyle Rose | Canaccord Genuity |